Celiac disease: From gluten to skin

Expert Review of Clinical Immunology

Volumn 5, Issue 6, 2009, Pages 789-800

  Abenavoli, Ludovico ^a   Proietti, Ilaria ^b   Zaccone, Vincenzo ^c   Gasbarrini, Giovanni ^c   Addolorato, Giovanni ^c  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Alopecia areata; Celiac disease; Dermatitis herpetiformis; Malabsorption; Psoriasis; Skin

Indexed keywords

GLUTEN;

AUTOIMMUNE DISEASE; CELIAC DISEASE; ENTEROPATHY; GLUTEN FREE DIET; HUMAN; INTESTINE ABSORPTION; INTESTINE MOTILITY; INTESTINE VILLUS ATROPHY; REVIEW; SKIN DISEASE;

EID: 77949781473     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/eci.09.46     Document Type: Review

References (102)

1. Green PH, Jabri B. Coeliac disease. Lancet 362(9381), 383-391 (2003).
2. Green PH, Cellier C. Celiac disease. N. Engl. J. Med. 357(17), 1731-1743 (2007).
3. Rodrigo L. Celiac disease. World J. Gastroenterol. 12, 6585-6593 (2006).
4. Rostom A, Dube C, Cranney A et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 128(Suppl. 1), S38-S46 (2005).
5. Abenavoli L, Proietti I, Leggio L et al. Cutaneous manifestations in celiac disease. World J. Gastroenterol. 12, 843-852 (2006).
6. Seyhan M, Erdem T, Ertekin V et al. The mucocutaneous manifestations associated with celiac disease in childhood and adolescence. Pediatr. Dermatol. 24(1), 28-33 (2007).
7. Fry L. Dermatitis herpetiformis: problems, progress and prospects. Eur. J. Dermatol. 12, 523-531 (2002).
8. Seah PP, Fry L, Holborow EJ et al. Antireticulin antibody: incidence and diagnostic significance. Gut 14, 311-315 (1973).
9. Spurkland A, Ingvarsson G, Falk ES et al. Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (a 1*0501, b 1*02) or the HLA-DQ (a 1*03, b 1*0302) heterodimers. Tissue Antigens 49, 29-34 (1997).
10. Koskinen LL, Korponay-Szabo IR, Viiri K et al. Myosin IXB gene region and gluten intolerance: linkage to coeliac disease and a putative dermatitis herpetiformis association. J. Med. Genet. 45(4), 222-227 (2008).
11. Preisz K, Sardy M, Horvath A et al. Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis. J. Eur. Acad. Dermatol. Venereol. 19, 74-79 (2005).
12. Osman AA, Günnel T, Dietl A et al. B cell epitopes of gliadin. Clin. Exp. Immunol. 121(2), 248-254 (2000).
13. Nino M, Ciacci C, Delfino M. A longterm gluten-free diet as an alternative treatment in severe forms of dermatitis herpetiformis. J. Dermatolog. Treat. 18(1), 10-12 (2007).
14. Oxentenko AS, Murray JA. Celiac disease and dermatitis herpetiformis: the spectrum of gluten-sensitive enteropathy. Int. J. Dermatol. 42, 585-587 (2003).
15. Bardella MT, Fredella C, Trovato C et al. Long-term remission in patients with dermatitis herpetiformis on a normal diet. Br. J. Dermatol. 149(5), 968-971 (2003).
16. Gulliver W. Long-term prognosis in patients with psoriasis. Br. J. Dermatol. 159(Suppl. 2), 2-9 (2008).
17. Blauvelt A. T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis. J. Invest. Dermatol. 128(5), 1064-1067 (2008).
18. Veal CD, Capon F, Allen MH et al. Family-based analysis using a dense single-nucleotide polymorphism-based map defines genetic variation at PSORS1, the major psoriasis-susceptibility locus. Am. J. Hum. Genet. 71, 554-564 (2002).
19. + T cells in the development of T helper type 1 responses. J. Exp. Med. 195, 473-483 (2002).
20. Nestle FO. Psoriasis. Curr. Dir. Autoimmun. 10, 65-75 (2008).
21. Abenavoli L, Proietti I, Vonghia L et al. Intestinal malabsorption and skin diseases. Dig. Dis. 26(2), 167-174 (2008).
22. Ojetti V, Aguilar Sanchez J, Guerriero C et al. High prevalence of celiac disease in psoriasis. Am. J. Gastroenterol. 98, 2574-2575 (2003).
23. Ojetti V, De Simone C, Aguilar Sanchez J, et al. Malabsorption in psoriatic patients: cause or consequence? Scand. J. Gastroenterol. 41, 1267-1271 (2006).
24. Cardinali C, Deglinnocenti D, Caproni M et al. Is the search for serum antibodies to gliadin, endomysium and tissue transglutaminase meaningful in psoriatic patients? Relationship between the pathogenesis of psoriasis and celiac disease. Br. J. Dermatol. 147, 187-188 (2002).
25. Michaelsson G, Gerden B, Hagforsen E et al. Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet. Br. J. Dermatol. 142, 44-51 (2000).
26. Damasiewicz-Bodzek A, Wielkoszyński T. Serologic markers of celiac disease in psoriatic patients. J. Eur. Acad. Dermatol. Venereol. 22(9), 1055-1061 (2008).
27. Corazza GR, Andreani ML, Venturo N et al. Celiac disease and alopecia areata: report of a new association. Gastroenterology 109, 1333-1337 (1995).
28. Fessatou S, Kostaki M, Karpathios T. Coeliac disease and alopecia areata in childhood. J. Paediatr. Child. Health 39, 152-154 (2003).
29. Bardella MT, Marino R, Barbareschi M et al. Alopecia areata and coeliac disease: no effect of a gluten-free diet on hair growth. Dermatology 200(2), 108-110 (2000).
30. Bondavalli P, Quadri G, Parodi A et al. Failure of gluten-free diet in celiac disease-associated alopecia areata. Acta Derm. Venereol. 78(4), 319 (1998).
31. Viola F, Barbato M, Formisano M et al. Reappearance of alopecia areata in a coeliac patient during an unintentional challenge with gluten. Minerva Gastroenterol. Dietol. 45(4), 283-285 (1999).
32. Zampetti M, Filippetti R. Alopecia areata and celiac disease. G. Ital. Dermatol. Venereol. 143(2), 168 (2008).
33. Guide SV, Marinkovich MP. Linear IgA bullous dermatosis. Clin. Dermatol. 19(6), 719-727 (2001).
34. Caproni M, Rolfo S, Bernacchi E et al. The role of lymphocytes, granulocytes, mast cells and their related cytokines in lesional skin of linear IgA bullous dermatosis. Br. J. Dermatol. 140(6), 1072-1078 (1999).
35. Egan CA, Smith EP, Taylor TB et al. Linear IgA bullous dermatosis responsive to a gluten-free diet. Am. J. Gastroenterol. 96(6), 1927-1929 (2001).
36. Poonawalla T, Kelly B. Urticaria: a review. Am. J. Clin. Dermatol. 10(1), 9-21 (2001).
37. Hautekeete ML, DeClerck LS, Stevens WJ. Chronic urticaria associated with coeliac disease. Lancet 1, 157 (1987).
38. Cooper BT, Holmes GK, Cooke WT. Coeliac disease and immunological disorders. Br. Med. J. 1, 537-539 (1978).
39. Scala E, Giani M, Pirrotta L et al. Urticaria and adult celiac disease. Allergy 54, 1008-1009 (1999).
40. Caminiti L, Passalacqua G, Magazzù G et al. Chronic urticaria and associated CD in children: a case-control study. Ped. Allergy Immunol. 16, 428-432 (2005).
41. Adhikesavan LG, Olenginski TP. Hereditary angioedema in a family presenting as transient periarthritis. J. Clin. Rheumatol. 14(5), 289-291 (2008).
42. Brickman CM, Tsokos GC, Chused TM et al. Immunoregulatory disorders associated with hereditary angioedema II. Serologic and cellular abnormalities. J. Allergy Clin. Immunol. 77, 758-767 (1986).
43. Farkas H, Gyeney L, Nemesanszky E et al. Coincidence of hereditary angioedema (HAE) with Crohns disease. Immunol. Invest. 28, 43-53 (1999).
44. Unsworth DJ, Wurzner R, Brown DL et al. Extracts of wheat gluten activate complement via the alternative pathway. Clin. Exp. Immunol. 94, 539-543 (1993).
45. Farkas H, Visy B, Fekete B et al. Association of celiac disease and hereditary angioneurotic edema. Am. J. Gastroenterol. 97, 2682-2683 (2002).
46. Alegre VA, Winkelmann RK, Diez-Martin JL et al. Adult celiac disease, small and medium vessel cutaneous necrotizing vasculitis, and T cell lymphoma. Am. Acad. Dermatol. 19, 973-978 (1988).
47. Meyers S, Dikman S, Spiera H et al. Cutaneous vasculitis complicating coeliac disease. Gut 22, 61-64 (1981).
48. Cribier B, Caille A, Heid E et al. Erythema nodosum and associated diseases. A study of 129 cases. Int. J. Dermatol. 37, 667-672 (1998).
49. Durand JM, Lefevre P, Weiller C. Erythema nodosum and coeliac disease. Br. J. Dermatol. 125, 291-292 (1991).
50. Bartyik K, Varkonyi A, Kirschner A et al. Erythema nodosum in association with celiac disease. Pediatr. Dermatol. 21, 227-230 (2004).
51. Douglas JG, Gillon J, Logan RF et al. Sarcoidosis and coeliac disease: an association? Lancet 2, 13-15 (1984).
52. Crowson AN, Mihm MC Jr, Magro CM. Cutaneous vasculitis: a review. Cutan. Pathol. 30(3), 161-173 (2003).
53. Tasanen K, Raudasoja R, Kallioinen M et al. Erythema elevatum diutinum in association with coeliac disease. Br. J. Dermatol. 136, 624-627 (1997).
54. Becker SW, Kahn D, Rothman S. Cutaneous manifestation of internal malignant tumors. Arch. Dermatol. Syph. 45, 1069-1080 (1942).
55. Wilkinson DS. Necrolytic migratory erythema with carcinoma of the pancreas. Trans. St Johns Hosp. Dermatol. Soc. 59, 244-250 (1973).
56. Adam DN, Cohen PD, Ghazarian D. Necrolytic migratory erythema: case report and clinical review. J. Cutan. Med. Surg. 7(4), 333-338 (2003).
57. Goodenberger DM, Lawley TJ, Strober W et al. Necrolytic migratory erythema without glucagonoma: report of two cases. Arch. Dermatol. 115, 1429-1432 (1979).
58. Kelly CP, Johnston CF, Nolan N et al. Necrolytic migratory erythema with elevated plasma enteroglucagon in celiac disease. Gastroenterology 96, 1350-1353 (1989).
59. Thorisdottir K, Camisa C, Tomecki KJ et al. Necrolytic migratory erythema: a report of three cases. J. Am. Acad. Dermatol. 30, 324-329 (1994).
60. Grimes PE. New insights and new therapies in vitiligo. JAMA 293, 730-735 (2005).
61. Collin P, Reunala T. Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologist. Am. J. Clin. Dermatol. 4, 13-20 (2003).
62. Volta U, Bardazzi F, Zauli D et al. Serological screening for CD in vitiligo and alopecia areata. Br. J. Dermatol. 136, 801-802 (1997).
63. Fresko I, Yazici H. Treatment strategies for Behçets disease. Expert Opin Pharmacother. 9(18), 3211-3219 (2008).
64. Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behçets disease. Yonsei Med. J. 48(4), 573-585 (2007).
65. Field EA, Allan RB. Review article: oral ulceration - aetiopathogenesis, clinical diagnosis and management in the gastrointestinal clinic. Aliment. Pharmacol. Ther. 18(10), 949-962 (2003).
66. Triolo G, Triolo G, Accardo-Palumbo A et al. Behçets disease and coeliac disease. Lancet 346, 1495 (1995).
67. Muñoz-Corcuera M, Esparza-Gómez G, González-Moles MA et al. Oral ulcers: clinical aspects. A tool for dermatologists. Part II. Chronic ulcers. Clin. Exp. Dermatol. 34(4), 456-461 (2009).
68. Field EA, Allan RB. Review article: oral ulceration-aetiopathogenesis, clinical diagnosis and management in the gastrointestinal clinic. Aliment. Pharmacol. Ther. 18(10), 949-962 (2003).
69. Campisi G, Di Liberto C, Carroccio A et al. Coeliac disease: oral ulcer prevalence, assessment of risk and association with gluten-free diet in children. Dig. Liver Dis. 40(2), 104-107 (2008).
70. Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J. Am. Dent. Assoc. 134, 200-207 (2003).
71. Hunter IP, Ferguson MM, Scully C et al. Effects of dietary gluten elimination in patients with recurrent minor aphthous stomatitis and no detectable gluten enteropathy. Oral Surg. Oral Med. Oral Pathol. 75, 595-598 (1993).
72. Krathen MS, Fiorentino D, Werth VP. Dermatomyositis. Curr. Dir. Autoimmun. 10, 313-332 (2008).
73. Volta U, De Franceschi L, Molinaro N et al. Organ-specific autoantibodies in coeliac disease: do they represent an epiphenomenon or the expression of associated autoimmune disorders? Ital. J. Gastroenterol. Hepatol. 29, 18-21 (1997).
74. Evron E, Abarbanel JM, Branski D et al. Polymyositis, arthritis, and proteinuria in a patient with adult celiac disease. J. Rheumatol. 23, 782-783 (1996).
75. Marie I, Lecomte F, Hachulla E et al. An uncommon association: celiac disease and dermatomyositis in adults. Clin. Exp. Rheumatol. 19, 201-203 (2001).
76. Twaddle S, Wassif WS, Deacon AC et al. Celiac disease in patients with variegate porphyria. Dig. Dis. Sci. 46, 1506-1508 (2001).
77. Moore MR, Disler PB. Drug sensitive diseases - I - acute porphyrias. Adverse Drug React. Bull. 129, 484-487 (1988).
78. Addolorato G, Di Giuda D, De Rossi G et al. Regional cerebral hypoperfusion in patients with celiac disease. Am. J. Med. 116(5), 312-317 (2004).
79. Hovenden AL. Acquired hypertrichosis lanuginosa associated with malignancy. Arch. Intern. Med. 147, 2013-2018 (1987).
80. Corazza GR, Masina M, Passarini B et al. Acquired hypertrichosis lanuginosa associated with celiac syndrome. G. Ital. Dermatol. Venereol. 123, 611-612 (1988).
81. Oji V, Traupe H. Ichthyoses: differential diagnosis and molecular genetics. Eur. J. Dermatol. 16(4), 349-359 (2006).
82. Shwayder T. Disorders of keratinization: diagnosis and management. Am. J. Clin. Dermatol. 5, 17-29 (2004).
83. Menni S, Boccardi D, Brusasco A. Ichthyosis revealing celiac disease. Eur. J. Dermatol. 10, 398-399 (2000).
84. Karthikeyan K, Thappa DM. Pellagra and skin. Int. J. Dermatol. 41(8), 476-481 (2002).
85. Schattner A. A 70-year-old man with isolated weight loss and a pellagra-like syndrome due to celiac disease. Yale J. Biol. Med. 72, 15-18 (1999).
86. Koch SE, Williams ML. Acquired cutis laxa: case report and review of disorders of elastolysis. Pediatr. Dermatol. 2, 282-288 (1985).
87. De Schepper S, Loeys B, De Paepe A et al. Cutis laxa of the autosomal recessive type in a consanguineous family. Eur. J. Dermatol. 13(6), 529-533 (2003).
88. Lewis FM, Lewis-Jones S, Gipson M. Acquired cutis laxa with dermatitis herpetiformis and sarcoidosis. J. Am. Acad. Dermatol. 29, 846-848 (1993).
89. Bodvarsson S, Jonsdottir I, Freysdottir J et al. An autoimmune disease due to cross-reaction between dietary glutenin and dermal elastin? Scand. J. Immunol. 38, 546-550 (1993).
90. García-Patos V, Pujol RM, Barnadas MA et al. Generalized acquired cutis laxa associated with coeliac disease: evidence of immunoglobulin A deposits on the dermal elastic fibres. Br. J. Dermatol. 135(1), 130-134 (1996).
91. Watson WC, Paton E, Murray D. Small bowel disease in rosacea. Lancet 1(7402), 47-50 (1965).
92. Marks R, Whittle MW, Beard RJ et al. Small-bowel abnormalities in dermatitis herpetiformis. Br. Med. J. 1(5591), 552-555 (1968).
93. Montalto M, Diociaiuti A, Alvaro G et al. Atypical mole syndrome and congenital giant naevus in a patient with celiac disease. Panminerva Med. 45, 219-221 (2003).
94. Beber T. Atopic dermatitis. N. Engl. J. Med. 358(14), 1483-1494 (2008).
95. Avgerinou G, Goules AV, Stavropoulos PG et al. Atopic dermatitis: new immunologic aspects. Int. J. Dermatol. 47(3), 219-224 (2008).
96. Potapova OV, Luzgina NG, Shkurupiy VA. Immunomorphological study of Langerhans cells in the skin of patients with atopic dermatitis. Bull. Exp. Biol. Med. 146(6), 809-811 (2008).
97. Räsänen L, Lehto M, Turjanmaa K et al. Allergy to ingested cereals in atopic children. Allergy 49(10), 871-876 (1994).
98. Bjarnason I, Goolamali SK, Levi AJ et al. Intestinal permeability in patients with atopic eczema. Br. J. Dermatol. 112(3), 291-297 (1985).
99. Gallo C, Vighi G, Schroeder J et al. Chronic urticaria atopic dermatitis and celiac disease. Am. J. Gastroenterol. 87(11), 1684 (1992).
100. Jafroodi M, Zargari O, Hoda S. Concomitant Hodgkins lymphoma and atopic dermatitis in a child with celiac disease. Arch. Iran. Med. 12(3), 317-319 (2009).
101. Jollid LM, Jabri B. Is celiac disease an autoimmune disorder? Curr. Opin. Immunol. 17, 595-600 (2005).
102. Jones FA. The skin: a mirror of the gut. Geriatrics 28, 75-81 (1973).